Trial Profile
A Phase 3 Multicenter, Randomized, Controlled, Double-Masked Study of Safety and Efficacy of Sodium Hyaluronate Ophthalmic Solution, 0.18% in Dry Eye Syndrome
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Hyaluronic acid (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Alcon
- 28 Aug 2014 New trial record